Establishing a Stable Production and Supply System for Pharmaceutical-Related Products
First written in FY2022. 1 of 2 entries say "Advanced", first in FY2026. Latest entry: FY2026.
The whole theme swung hardest in 2023: 1 of 6 companies on the "Worse" side.
3 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Two contract development products that we had been working on for some time were successfully launched. We are therefore advancing initiatives to expand our range of new GMP intermediates and identify the next major products.」
For pharmaceutical-related products, 2 contract development products were launched, marking progress toward expanding new GMP intermediates and identifying the next major products. - FY2022First statedAnnual report
「We recognize improving the profitability of existing products, expanding globally, and establishing a stable production and supply system for pharmaceutical-related products as key issues. As a measure, we will steadily make the maintenance investments necessary for stable production and supply at the Fukuyama Plant of Manac Co., Ltd., a Group company.」
In the fine chemicals business, the Company identified improving the profitability of existing products and expanding globally as key issues, and aims to ensure stable production and supply of pharmaceutical-related products through maintenance investment at the Fukuyama Plant.